A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

NCT05704361 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: RO7121932 IV
DRUG: RO7121932 SC

Sponsor

Hoffmann-La Roche